India, Feb. 1 -- The Government of India has issued a release:
The Union Budget 2026-27, presented by the Hon'ble Union Minister for Finance and Corporate Affairs Smt. Nirmala Sitharaman in the Parliament today, has announced several key initiatives to strengthen India's pharmaceutical and biopharma sector. The Finance Minister stated that the Government has undertaken comprehensive economic reforms towards creating employment, boosting productivity and accelerating growth. The Minister emphasised scaling up of manufacturing in 7 strategic and frontier sectors including Pharmaceuticals to further accelerate and sustain economic growth.
Biopharma SHAKTI to Position India as a Global Biomanufacturing Hub
Underlining the importance of Biolo...